Olmert lightens ATM tariff regulations

The Central Bank requested the move, which is designed to increase the number of ATMs in areas with few branches due to the lack of economic viability.

By YIGAL GRAYEFF
December 15, 2005 07:44

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Finance Minister Ehud Olmert has removed regulatory oversight on the amount that banks can charge for transactions carried out at automatic teller machines located more than 500 meters from their branches, the Bank of Israel said Wednesday. However, the charge for withdrawing cash from ATMs close to the branches will remain at NIS 1.21. The Central Bank requested the move, which is designed to increase the number of ATMs in areas with few branches due to the lack of economic viability.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS